Ivy Prohealth Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-12-2024
- Paid Up Capital ₹ 1.20 M
as on 17-12-2024
- Company Age 4 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 151.95%
(FY 2022)
- Ebitda 94.85%
(FY 2022)
- Net Worth 26.91%
(FY 2022)
- Total Assets 399.14%
(FY 2022)
About Ivy Prohealth Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Randhir Yatan, Parwati Dwivedi, Santosh Dwivedi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300MH2020PTC350509
- Company No.
350509
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ivy Prohealth Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Dwivedi  | Director | 23-Nov-2020 | Current |
| Randhir Yatan | Director | 23-Nov-2020 | Current |
| Parwati Dwivedi | Director | 23-Nov-2020 | Current |
| Roshani Singh | Director | 23-Nov-2020 | Current |
Financial Performance of Ivy Prohealth Solutions.
Ivy Prohealth Solutions Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 151.95% increase in profit. The company's net worth Soared by an impressive increase of 26.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ivy Prohealth Solutions?
Unlock access to Ivy Prohealth Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Komal Engineers And Consultants Private LimitedActive 20 years 6 monthsRandhir Yatan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ivy Prohealth Solutions?
Ivy Prohealth Solutions has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ivy Prohealth Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ivy Prohealth Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
